Thursday, February 2 | Disruption of axonal transport is an early event in several neurodegenerative diseases. For this reason, it is a potential target for drug discovery. Register today to hear Dr Glennon discuss this exciting topic in Alzheimer's research including, how the disruption of axonal transport contributes to the development of Alzheimer's disease, and the mechanisms of axonal transport of the Alzheimer's amyloid precursor protein, and how these are altered in the disease.